Disposable Surgical Robotic Device - BIG News Coming 8/17/20

NASDAQ:MBOT   Microbot Medical Inc.
Microbot Medical Inc., a pre-clinical medical device company, researches, designs, and develops micro-robotics assisted medical technologies targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable self-propelled locomotive device to treat capabilities within tubular lumens, such as the blood vessels, respiratory, and the urinary and GI tracts; a combination of a guidewire and microcatheter technologies that are used for endoluminal surgery; and maneuver guidewire, microcatheters, and over-the-wire devices within the body's vasculature. It has 37 issued/allowed patents and 15 patent applications pending worldwide. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.

Microbot Medical to Share Current Results of a Feasibility Animal Study Utilizing the LIBERTY Robotic System

Results to be shared on August 17th during Needham’s Virtual Med Tech & Diagnostics Conference

HINGHAM, Mass., Aug. 13, 2020 (GLOBE NEWSWIRE) -- At the upcoming Needham Virtual Med Tech & Diagnostics Conference, being held on Monday, August 17, 2020, Microbot Medical Inc. (Nasdaq: MBOT), will provide initial results of a feasibility animal study performed using the Company’s LIBERTY Robotic System.

On 1/13/20, H.C. Wainwright maintained a Buy rating on MBOT and raised the price target from $12 to $26.00.

I think this device could be a game changer.

Disposable medical devices is where the future is going especially for sanitary reasons.

Watch this stock Monday, 8/17/2020, it could run hard.

I think the stock has been consolidating for a while and is coiling and ready to explode higher.


The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.


The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.